Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Celtic Biotech Ltd. is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, KINGDON, CATHY, who is the busiest examiner with 1 pending office action. The action is located within 1 distinct art unit, reflecting a singular focus for the company's current pending biotechnology prosecution.
Because there is only 1 pending office action, the company's entire current engagement with the patent office is concentrated under 1 distinct examiner. This 1 distinct art unit provides the departmental framework for the review. Practitioners should be aware that with only one matter pending, the company's current prosecution profile is highly sensitive to the individual discretion of KINGDON, CATHY within the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KINGDON, CATHY | 1 | 80.3% | +2.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18855454 | STABILIZED FORMULA OF CROTOXIN | KINGDON, CATHY | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18855454 | STABILIZED FORMULA OF CROTOXIN | KINGDON, CATHY | 1653 | §103§112DP | Non-Final OA | — | Pending | Dec 31, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCeltic Biotech Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Cathy Kingdon has the most, with 1 of Celtic Biotech Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
